Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival.
Muchtar E, Dispenzieri A, Kumar SK, Buadi FK, Lacy MQ, Zeldenrust S, Hayman SR, Leung N, Kourelis TV, Gonsalves W, Chakraborty R, Russell S, Dingli D, Lust JA, Lin Y, Kapoor P, Go R, Kyle RA, Rajkumar SV, Gertz MA.
Muchtar E, et al.
Leukemia. 2017 Jan;31(1):92-99. doi: 10.1038/leu.2016.140. Epub 2016 May 23.
Leukemia. 2017.
PMID: 27211265